Loading live market data…

Novavax, Inc.

NASDAQ:NVAX

$8.42 USD

-$0.49 (-5.5%)

Volume
3.8M
Average Volume
4.86M
Market Capitalization
$1.38B
P/E Ratio
-15.59
Dividend Yield
0.00%
Price Target
$18.00
Year High
$11.97
Year Low
$6.20
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$2.48
Source Headline
Novavax (NVAX) Stock Sinks As Market Gains: Here's Why

In the latest trading session, Novavax (NVAX) closed at $8.42, marking a -5.5% move from the previous day.

zacks.com - 2026-07-14 18:45:33

Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights

Novavax (NVAX) concluded the recent trading session at $9.35, signifying a -1.16% move from its prior day's close.

zacks.com - 2026-07-08 18:46:21

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.

zacks.com - 2026-07-07 10:01:10

Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights

In the closing of the recent trading day, Novavax (NVAX) stood at $8.9, denoting a -1.17% move from the preceding trading day.

zacks.com - 2026-06-24 18:47:15

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

RALEIGH, N.C., June 24, 2026 (GLOBE NEWSWIRE) -- Shah Capital, the largest shareholder of Novavax, today commented on yesterday's announced voting results from Novavax's June 18th 2026 Annual Meeting of Stockholders.

globenewswire.com - 2026-06-24 08:00:00

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-23 10:01:04

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

Novavax (NVAX) closed the most recent trading day at $9.13, moving 3.89% from the previous trading session.

zacks.com - 2026-06-18 18:46:10

Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Moderna (NASDAQ:MRNA | MRNA Price Prediction) stock is jumping again.

247wallst.com - 2026-06-16 15:21:15

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade

Novavax (NVAX) closed the most recent trading day at $8.88, moving 1.66% from the previous trading session.

zacks.com - 2026-06-12 18:45:31

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-06-08 10:01:13

Novavax (NVAX) Up 10.4% Since Last Earnings Report: Can It Continue?

Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-05 12:35:51

Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Jefferies Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-06-04 13:11:52

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

GAITHERSBURG, Md., June 1, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will participate in the 2026 Jefferies Global Healthcare Conference.

prnewswire.com - 2026-06-01 16:00:00

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

zacks.com - 2026-05-26 10:01:10

Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Novavax, Inc. (NVAX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

seekingalpha.com - 2026-05-13 22:20:42

3 Reasons Not to Buy Into the Hantavirus-Related Biotech Rally

The hantavirus isn't as contagious as the coronavirus, making a global pandemic unlikely. Picking the potential winners in the hantavirus vaccine market would hardly be worth the time and risk.

fool.com - 2026-05-13 13:15:00

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know

Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

zacks.com - 2026-05-12 10:01:12

Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near $57.52 after Friday's close of $54.35.

247wallst.com - 2026-05-11 10:53:37

Hantavirus Scare Sparks Vaccine Stock Rally: Moderna, Novavax Climb

Moderna Inc. (NASDAQ:MRNA) and Novavax Inc. (NASDAQ:NVAX) shares moved higher Monday as traders piled back into vaccine names following renewed concerns over a hantavirus outbreak tied to the MV Hondius cruise ship.

benzinga.com - 2026-05-11 09:29:51

Hantavirus cases spark surge in pharma and biotech stocks — here's why

Several pharmaceutical stocks are rising in premarket trading in the wake of a hantavirus outbreak. Moderna, Inovio, Novavax, and Emergent Biosolutions rose in early market trading.

cnbc.com - 2026-05-11 07:53:49

What's Going On With Novavax Stock On Friday?

Novavax Inc. (NASDAQ:NVAX) stock is trading higher on Friday in reaction to a surge in Moderna Inc. (NASDAQ:MRNA).

benzinga.com - 2026-05-08 14:18:06

Novavax to Participate in BofA Securities 2026 Health Care Conference

GAITHERSBURG, Md., May 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2026 Health Care Conference.

prnewswire.com - 2026-05-07 16:00:00

NVAX Q1 Earnings Beat, Stock Jumps 16% on Matrix-M Deal Momentum

Novavax's shares rise 16% after Q1 earnings beat estimates as the company expands Matrix-M partnerships across oncology and infectious diseases.

zacks.com - 2026-05-07 12:16:42

Why Novavax Stock Is Trading Higher On Wednesday?

Novavax Inc. (NASDAQ:NVAX) shares are trading higher on Wednesday after the company reported better-than-expected first-quarter financial results.

benzinga.com - 2026-05-06 15:07:12

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

Novavax, Inc. (NVAX) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 14:21:17

Novavax (NVAX) Reports Q1 Loss, Beats Revenue Estimates

Novavax (NVAX) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to earnings of $2.93 per share a year ago.

zacks.com - 2026-05-06 10:30:33

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M ®  in two infectious disease areas  In April, Novavax signed a new MTA with a top 10 leading pharmaceutical company and leader in oncology to explore Matrix-M in multiple oncology and infectious disease targets In April, Novavax expanded an existing partnership with a new MTA, providing access to Matrix-M for exploration in up to nine additional identified infectious diseases In February, Novavax expanded an existing MTA with a major global pharmaceutical company to explore an additional field and signed a new MTA with an oncology company Sanofi announced positive results from the Phase 4 COMPARE study, a head-to-head study comparing Nuvaxovid™ and Moderna's mNEXSPIKE that reinforces Nuvaxovid's well established and differentiated reactogenicity profile Novavax's C. difficile vaccine candidate prioritized with potential to enter the clinic as early as 2027 Reiterates 2026 Revenue Framework and Combined R&D and SG&A expense guidance GAITHERSBURG, Md.

prnewswire.com - 2026-05-06 08:00:00

Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know

Novavax (NVAX) concluded the recent trading session at $8.01, signifying a +1.01% move from its prior day's close.

zacks.com - 2026-05-01 18:45:23

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.

zacks.com - 2026-05-01 09:55:41

Kura Oncology (KURA) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Kura Oncology (KURA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-30 11:01:39

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

GAITHERSBURG, Md., April 29, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced it will report its first quarter 2026 financial results and operational highlights at 8:30 a.m.

prnewswire.com - 2026-04-29 16:00:00

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

zacks.com - 2026-04-27 10:06:43

Novavax (NVAX) Outperforms Broader Market: What You Need to Know

Novavax (NVAX) concluded the recent trading session at $8.84, signifying a +2.31% move from its prior day's close.

zacks.com - 2026-04-17 18:46:06

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.

zacks.com - 2026-04-15 09:56:11

Get NVAX Insider Trade Alerts

NVAX Price Target Summary

Last Month

$0.00

0 analysts

Last Quarter

$0.00

0 analysts

Last Year

$14.50

2 analysts

All Time

$39.25

8 analysts

NVAX Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-06-11 BTIG Maintain Buy Buy
2026-05-06 TD Cowen Maintain Hold Hold
2026-02-27 HC Wainwright & Co. Maintain Buy Buy
2026-01-20 BTIG Maintain Buy Buy
2025-11-18 JP Morgan Maintain Underweight Underweight
2025-11-10 B. Riley Securities Maintain Buy Buy
2025-11-04 TD Cowen Maintain Hold Hold
2025-10-23 HC Wainwright & Co. Maintain Buy Buy
2025-08-20 B of A Securities Downgrade Neutral Underperform
2025-07-22 B of A Securities Maintain Neutral Neutral
2025-05-09 JP Morgan Maintain Underweight Underweight
2024-12-10 HC Wainwright & Co. Maintain Buy Buy
2024-11-13 HC Wainwright & Co. Maintain Buy Buy
2024-11-12 HC Wainwright & Co. Maintain Buy Buy
2024-08-12 JP Morgan Maintain Underweight Underweight
2024-08-12 B. Riley Securities Maintain Buy Buy
2024-08-02 B. Riley Securities Maintain Buy Buy
2024-07-30 JP Morgan Downgrade Neutral Underweight
2024-06-14 B of A Securities Maintain Neutral Neutral
2024-05-23 B. Riley Securities Maintain Buy Buy
2024-05-13 TD Cowen Maintain Hold Hold
2024-05-13 HC Wainwright & Co. Maintain Buy Buy
2024-05-10 B of A Securities Upgrade Underperform Neutral
2024-03-01 HC Wainwright & Co. Maintain Buy Buy
2024-02-23 B. Riley Securities Maintain Buy Buy
2023-08-10 HC Wainwright & Co. Maintain Buy Buy
2023-08-09 B. Riley Securities Upgrade Neutral Buy
2023-05-10 HC Wainwright & Co. Maintain Buy Buy
2023-03-01 B. Riley Securities Downgrade Buy Neutral
2023-02-13 HC Wainwright & Co. Maintain Buy Buy
2023-01-02 HC Wainwright & Co. Maintain Buy Buy
2022-10-14 B. Riley Securities Maintain Buy Buy
2022-09-22 JP Morgan Downgrade Neutral Underweight
2022-08-09 Cowen & Co. Maintain Outperform Outperform
2022-06-08 Cantor Fitzgerald Maintain Overweight Overweight
2022-05-20 B of A Securities Maintain Underperform Underperform
2022-04-26 B. Riley Securities Maintain Buy Buy
2022-03-03 HC Wainwright & Co. Maintain Buy Buy
2022-01-21 Cowen & Co. Maintain Outperform Outperform
2021-12-21 JP Morgan Maintain Neutral Neutral
2021-06-15 Cantor Fitzgerald Maintain Overweight Overweight
2021-05-12 HC Wainwright & Co. Maintain Buy Buy
2021-05-12 Cantor Fitzgerald Maintain Overweight Overweight
2021-05-12 JP Morgan Downgrade Overweight Neutral
2021-03-12 HC Wainwright & Co. Maintain Buy Buy
2021-02-18 B. Riley Securities Maintain Buy Buy
2021-02-18 B. Riley FBR Maintain Buy Buy
2021-02-17 B. Riley FBR Maintain Buy Buy
2021-02-05 Cantor Fitzgerald Maintain Overweight Overweight
2021-02-01 B. Riley Securities Maintain Buy Buy
2021-02-01 B. Riley FBR Maintain Buy Buy
2021-01-31 B. Riley FBR Maintain Buy Buy
2020-12-14 Jefferies Maintain Buy Buy
2020-11-25 HC Wainwright & Co. Maintain Buy Buy
2020-11-25 Cantor Fitzgerald Maintain Overweight Overweight
2020-11-25 Citigroup Downgrade Buy Neutral
2020-11-25 JP Morgan Upgrade Underweight Overweight
2020-11-25 PiperJaffray Downgrade Overweight Neutral
2020-11-25 PiperJaffray Maintain Overweight Overweight
2020-11-25 JP Morgan Downgrade Overweight Neutral
2020-11-25 Ladenburg Thalmann Downgrade Buy Neutral
2020-11-25 JP Morgan Maintain Overweight Overweight
2020-11-25 Citigroup Upgrade Neutral Buy
2020-11-25 Cantor Fitzgerald Upgrade Neutral Overweight
2020-11-25 Seaport Global Upgrade Neutral Buy
2020-11-25 Oppenheimer Maintain Outperform Outperform
2020-11-25 McNicoll Lewis Vlak Maintain Buy Buy
2020-11-25 PiperJaffray Upgrade Neutral Overweight
2020-11-25 Chardan Capital Maintain Neutral Neutral
2020-11-25 Ladenburg Thalmann Upgrade Neutral Buy
2020-11-25 B. Riley FBR Maintain Buy Buy
2020-11-25 Wedbush Downgrade Buy Neutral
2020-11-25 Citi Maintain Buy Buy
2020-11-25 Citigroup Maintain Buy Buy
2020-11-25 Lazard Maintain Buy Buy
2020-11-17 HC Wainwright & Co. Maintain Buy Buy
2020-08-06 HC Wainwright & Co. Maintain Buy Buy
2020-08-05 Ladenburg Thalmann Downgrade Neutral Sell
2020-08-05 JP Morgan Upgrade Neutral Overweight
2020-08-05 B. Riley FBR Maintain Buy Buy
2020-08-05 B. Riley Securities Maintain Buy Buy
2020-07-16 HC Wainwright & Co. Maintain Buy Buy
2020-07-08 Ladenburg Thalmann Downgrade Buy Neutral
2020-06-29 B. Riley FBR Maintain Buy Buy
2020-06-29 B. Riley Securities Maintain Buy Buy
2020-06-29 HC Wainwright & Co. Maintain Buy Buy
2020-06-19 Cantor Fitzgerald Maintain Overweight Overweight
2020-06-05 JP Morgan Upgrade Underweight Neutral
2020-05-28 B. Riley Securities Maintain Buy Buy
2020-05-28 B. Riley FBR Maintain Buy Buy
2020-05-18 B. Riley FBR Maintain Buy Buy
2020-05-18 B. Riley Securities Maintain Buy Buy
2020-05-12 B. Riley FBR Maintain Buy Buy
2020-05-12 H.C. Wainwright Maintain Buy Buy
2020-05-12 B. Riley Securities Maintain Buy Buy
2020-05-12 Oppenheimer Maintain Outperform Outperform
2020-05-12 Cantor Fitzgerald Maintain Overweight Overweight
2020-04-30 HC Wainwright & Co. Maintain Buy Buy
2020-04-24 B. Riley Securities Maintain Buy Buy
2020-04-24 B. Riley FBR Maintain Buy Buy
2020-03-27 B. Riley FBR Maintain Buy Buy
2020-03-27 B. Riley Securities Maintain Buy Buy
2020-03-25 H.C. Wainwright Maintain Buy Buy
2020-03-25 Cantor Fitzgerald Maintain Overweight Overweight
2020-03-17 Cantor Fitzgerald Upgrade Neutral Overweight
2020-02-28 B. Riley FBR Maintain Buy Buy
2020-02-28 B. Riley Securities Maintain Buy Buy
2019-09-24 Citi Maintain Buy Buy
2019-09-24 Citigroup Maintain Buy Buy
2019-09-10 Oppenheimer Maintain Outperform Outperform
2019-03-04 B. Riley FBR Maintain Buy Buy
2019-03-04 B. Riley Securities Maintain Buy Buy
2019-02-28 Piper Sandler Downgrade Overweight Underweight
2019-02-28 JP Morgan Downgrade Overweight Underweight
2019-02-28 PiperJaffray Downgrade Overweight Underweight
2019-01-28 H.C. Wainwright Maintain Buy Buy
2018-12-11 Oppenheimer Maintain Outperform Outperform
2018-11-26 PiperJaffray Upgrade Neutral Overweight
2018-11-26 Piper Sandler Upgrade Neutral Overweight
2018-09-21 JP Morgan Upgrade Underweight Overweight
2018-03-29 Seaport Global Upgrade Neutral Buy
2018-03-19 JP Morgan Downgrade Neutral Underweight
2018-02-21 Citigroup Maintain Neutral Neutral
2018-01-10 B. Riley Securities Maintain Buy Buy
2018-01-10 B. Riley Maintain Buy Buy
2018-01-10 B. Riley FBR Maintain Buy Buy
2018-01-05 B. Riley FBR Maintain Buy Buy
2018-01-05 B. Riley Maintain Buy Buy
2017-12-19 Citigroup Downgrade Buy Neutral
2017-10-31 Citigroup Upgrade Neutral Buy
2017-10-06 Seaport Global Maintain Neutral Neutral
2017-08-09 Ladenburg Thalmann Upgrade Neutral Buy
2016-12-16 Cantor Fitzgerald Maintain Neutral Neutral
2016-09-20 Chardan Capital Maintain Neutral Neutral
2016-09-19 Citigroup Maintain Neutral Neutral
2016-09-16 Piper Sandler Downgrade Overweight Neutral
2016-09-16 Ladenburg Thalmann Downgrade Buy Neutral
2016-09-16 JP Morgan Downgrade Overweight Neutral
2016-09-16 PiperJaffray Downgrade Overweight Neutral
2016-09-16 Wedbush Downgrade Buy Neutral
2016-09-16 Citigroup Downgrade Buy Neutral
2016-07-28 Citigroup Maintain Buy Buy
2016-04-04 Chardan Capital Maintain Neutral Neutral
2016-03-03 JP Morgan Maintain Overweight Overweight
2015-08-11 PiperJaffray Maintain Overweight Overweight
2015-08-11 Piper Sandler Maintain Overweight Overweight
2015-07-10 Citigroup Maintain Buy Buy
2014-10-07 JP Morgan Maintain Overweight Overweight
2014-09-19 Wedbush Maintain Outperform Outperform
2014-08-13 Citigroup Maintain Buy Buy
2014-02-03 McNicoll Lewis Vlak Maintain Buy Buy
2013-08-15 Lazard Maintain Buy Buy
2012-03-09 PiperJaffray Maintain Overweight Overweight